Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia

Nature Communications

Volumn 7, Issue , 2016, Pages

  Lilljebjörn, Henrik ^a   Henningsson, Rasmus ^a   Hyrenius Wittsten, Axel ^a   Olsson, Linda ^a   Orsmark Pietras, Christina ^a   Von Palffy, Sofia ^a   Askmyr, Maria ^a   Rissler, Marianne ^a   Schrappe, Martin ^b   Cario, Gunnar ^b   Castor, Anders ^c   Pronk, Cornelis J H ^c   Behrendtz, Mikael ^d   Mitelman, Felix ^a   Johansson, Bertil ^a,e   Paulsson, Kajsa ^a   Andersson, Anna K ^a   Fontes, Magnus ^a   Fioretos, Thoas ^a,e  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e NONE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DUX4; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; DUX4 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; ONCOPROTEIN;

CANCER; CELLS AND CELL COMPONENTS; DISEASE TREATMENT; GENE EXPRESSION; GENETIC ANALYSIS; MUTATION; PATHOGENICITY; RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; FUSION GENE; GENE DELETION; GENE EXPRESSION PROFILING; GENE FUSION; GENE REARRANGEMENT; HUMAN; MUTATIONAL ANALYSIS; PRE B LYMPHOCYTE; RNA SEQUENCE; ALTERNATIVE RNA SPLICING; CHILD; CHROMOSOME BREAKAGE; CLUSTER ANALYSIS; COHORT ANALYSIS; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; PRINCIPAL COMPONENT ANALYSIS;

ALTERNATIVE SPLICING; CHILD; CHROMOSOME BREAKAGE; CLUSTER ANALYSIS; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; GENE REGULATORY NETWORKS; HOMEODOMAIN PROTEINS; HUMANS; ONCOGENE PROTEINS, FUSION; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRINCIPAL COMPONENT ANALYSIS;

EID: 84973305001     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11790     Document Type: Article

References (59)

1. Pui, C.-H. & Evans, W. E. Treatment of acute lymphoblastic leukemia. N. Engl. J. Med. 354, 166-178 (2006).
2. Martinelli, G. et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report. J. Clin. Oncol. 27, 5202-5207 (2009).
3. Olsson, L. et al. Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. Leukemia 28, 302-310 (2014).
4. Den Boer, M. L. et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 10, 125-134 (2009).
5. Mullighan, C. G. et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N. Engl. J. Med. 360, 470-480 (2009).
6. Harvey, R. C. et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 116, 4874-4884 (2010).
7. Roberts, K. G. et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 22, 153-166 (2012).
8. Roberts, K. G. et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N. Engl. J. Med. 371, 1005-1015 (2014).
9. Papaemmanuil, E. et al. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat. Genet. 46, 116-125 (2014).
10. Fischer, U. et al. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options. Nat. Genet. 47, 1020-1029 (2015).
11. Paulsson, K. et al. The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Nat. Genet. 47, 672-676 (2015).
12. Holmfeldt, L. et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat. Genet. 45, 242-252 (2013).
13. Andersson, A. K. et al. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat. Genet. 47, 330-337 (2015).
14. Clappier, E. et al. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. Leukemia 28, 70-77 (2014).
15. Zaliova, M. et al. ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic. Leukemia 28, 182-185 (2014).
16. Lemmers, R. J. L. F. et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329, 1650-1653 (2010).
17. Snider, L. et al. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6, e1001181 (2010).
18. Pui, C.-H., Robison, L. L. & Look, A. T. Acute lymphoblastic leukaemia. Lancet 371, 1030-1043 (2008).
19. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
20. Niebuhr, B. et al. Runx1 is essential at two stages of early murine B-cell development. Blood 122, 413-423 (2013).
21. Schwickert, T. A. et al. Stage-specific control of early B cell development by the transcription factor Ikaros. Nat. Immunol. 15, 283-293 (2014).
22. Dörge, P. et al. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Haematologica 98, 428-432 (2013).
23. van der, Veer, A. et al. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL. Blood 122, 2622-2629 (2013).
24. Mitelman, F., Johansson, B. & Mertens, F. Mitelman database of chromosome aberrations and gene fusions in cancer; Available at http://cgap.nci.nih.gov/Chromosomes/Mitelman (2016).
25. Gocho, Y. et al. A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia. Leukemia 29, 2445-2448 (2015).
26. nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15, 2233-2239 (1997).
27. Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. 45, 860-867 (2013).
28. Martineau, M. et al. ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications. Genes Chromosomes Cancer 43, 54-71 (2005).
29. Jin, Y. et al. Determination of ETV6-RUNX1 genomic breakpoint by nextgeneration sequencing. Cancer Med. 5, 337-351 (2016).
30. Mertens, F., Johansson, B., Fioretos, T. & Mitelman, F. The emerging complexity of gene fusions in cancer. Nat. Rev. Cancer 15, 371-381 (2015).
31. Olsson, L. et al. Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1. Genes. Chromosomes Cancer 54, 315-325 (2015).
32. Olsson, L. & Johansson, B. Ikaros and leukaemia. Br. J. Haematol. 169, 479-491 (2015).
33. Filippakopoulos, P. & Knapp, S. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat. Rev. Drug Discov. 13, 337-356 (2014).
34. Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758-764 (2007).
35. Zaliova, M. et al. TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases. Pediatr. Blood Cancer 56, 217-225 (2011).
36. Yeoh, E.-J. et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1, 133-143 (2002).
37. Ross, M. E. et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102, 2951-2959 (2003).
38. van Delft, F. W. et al. Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemia. Br. J. Haematol. 130, 26-35 (2005).
39. Andersson, A. et al. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 21, 1198-1203 (2007).
40. Forbes, S. A. et al. The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr. Protoc. Hum. Genet. 57, 10.11.1-10.11.26 (2008).
41. Paulsson, K. et al. Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 47, 26-33 (2008).
42. Case, M. et al. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia. Cancer Res. 68, 6803-6809 (2008).
43. Kawamura-Saito, M. et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum. Mol. Genet 15, 2125-2137 (2006).
44. Geng, L. N. et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev. Cell 22, 38-51 (2012).
45. Iijima, K. et al. An analysis Of Ph-like ALL in Japanese patients. Blood 122, 352-352 (2013).
46. Lilljebjörn, H. et al. RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib. Leukemia 28, 977-979 (2014).
47. Schmiegelow, K. et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 24, 345-354 (2009).
48. Conter, V. et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 115, 3206-3214 (2010).
49. Iyer, M. K., Chinnaiyan, A. M. & Maher, C. A. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 27, 2903-2904 (2011).
50. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
51. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
52. Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM; Available at http://arxiv.org/abs/1303.3997 (2013).
53. Faust, G. G. & Hall, I. M. SAMBLASTER: fast duplicate marking and structural variant read extraction. Bioinformatics 30, 2503-2505 (2014).
54. Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811-1817 (2012).
55. Hastie, T., Tibshirani, R. & Friedman, J. The Elements of Statistical Learning (Springer, 2009).
56. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).
57. Koboldt, D. C. et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568-576 (2012).
58. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164-e164 (2010).
59. Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639-1645 (2009).